New clinical trial aims to improve heart protection during surgery in children
A new clinical trial being led by BHP founder-member the University of Birmingham and funded by the British Heart Foundation could help improve the recovery of children who undergo life-saving heart…
Researchers awarded vital funding to explore treatment to slow rare liver disease
LifeArc and PSC Support have jointly awarded £948,774 for new research into primary sclerosing cholangitis (PSC) – a rare disease where the body attacks its own liver, causing inflammation and scarri…
Birmingham research shapes new miscarriage guidelines
Research led by BHP founder-member the University of Birmingham has helped to shape guidelines which could mean thousands of women with prior miscarriage, and bleeding in early pregnancy, could be el…
New programme to train future mental health and neuroscience professionals
Future healthcare professionals working in mental health and neurosciences will be trained at a new Doctoral Training Programme (DTP) thanks to a multi-million award from Wellcome.
Led by the Univer…
New drug treatment regimen shows promise for patients with lupus
The results of a randomised controlled trial, published in Annals of Internal Medicine, found that a new drug treatment regimen – using belimumab soon after rituximab – reduced a disease-related auto…
Contraceptive pill can reduce type 2 diabetes risk in women with polycystic ovary syndrome
A study led by BHP founder-member the University of Birmingham has revealed for the first time that the contraceptive pill can reduce the risk of type 2 diabetes by over a quarter in women with polyc…